title: Novel therapeutic approaches for Leber's hereditary optic neuropathy.
abstract: Many human childhood mitochondrial disorders result from abnormal mitochondrial DNA (mtDNA) and altered bioenergetics. These abnormalities span most of the mtDNA, demonstrating that there are no "unique" positions on the mitochondrial genome that when deleted or mutated produce a disease phenotype. This diversity implies that the relationship between mitochondrial genotype and clinical phenotype is very complex. The origins of clinical phenotypes are thus unclear, fundamentally difficult-to-treat, and are usually clinically devastating. Current treatment is largely supportive and the disorders progress relentlessly causing significant morbidity and mortality. Vitamin supplements and pharmacological agents have been used in isolated cases and clinical trials, but the efficacy of these interventions is unclear. In spite of recent advances in the understanding of the pathogenesis of mitochondrial diseases, a cure remains elusive. An optimal cure would be gene therapy, which involves introducing the missing gene(s) into the mitochondria to complement the defect. Our recent research results indicate the feasibility of an innovative protein-transduction ("protofection") technology, consisting of a recombinant mitochondrial transcription factor A (TFAM) that avidly binds mtDNA and permits efficient targeting into mitochondria in situ and in vivo. Thus, the development of gene therapy for treating mitochondrial disease offers promise, because it may circumvent the clinical abnormalities and the current inability to treat individual disorders in affected individuals. This review aims to focus on current treatment options and future therapeutics in mitochondrial disease treatment with a special emphasis on Leber's hereditary optic neuropathy.
authors.affiliation: Center for the Study of Biological Complexity, Virginia Commonwealth University, Richmond, Virginia 23284, USA. siyer@vcu.edu
authors.forename: Shilpa
authors.initials: S
authors.lastname: Iyer
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D004272:DNA, Mitochondrial / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000378:metabolism; D019587:Dietary Supplements; D004195:Disease Models, Animal; D005260:Female; D015316:Genetic Therapy / Q000379:methods; D006801:Humans; D008297:Male; D008928:Mitochondria / Q000378:metabolism; D024101:Mitochondrial Proteins / Q000378:metabolism; D009154:Mutation; D029242:Optic Atrophy, Hereditary, Leber / Q000235:genetics / Q000503:physiopathology / Q000628:therapy*; D018384:Oxidative Stress; D010641:Phenotype; D011994:Recombinant Proteins / Q000378:metabolism; D014157:Transcription Factors / Q000378:metabolism; D014451:Ubiquinone / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000975:Antioxidants; D004272:DNA, Mitochondrial; D004268:DNA-Binding Proteins; D024101:Mitochondrial Proteins; D011994:Recombinant Proteins; D014157:Transcription Factors; C422562:mitochondrial transcription factor A; D014451:Ubiquinone; C036619:idebenone
references.citation: Arch Biochem Biophys. 1996 Jun 15;330(2):395-400
references.pmid: 8660670
references.citation: J Biol Chem. 2005 Jul 15;280(28):25994-6001
references.pmid: 15849190
references.citation: Mol Ther. 2003 Apr;7(4):550-7
references.pmid: 12727119
references.citation: Brain. 2013 Feb;136(Pt 2):e230
references.pmid: 23388409
references.citation: Mol Ther. 2003 Jun;7(6):720-30
references.pmid: 12788645
references.citation: J Neurol Sci. 1998 Jun 11;158(1):24-9
references.pmid: 9667773
references.citation: Biochem Biophys Res Commun. 1993 Oct 29;196(2):810-5
references.pmid: 8240356
references.citation: Am J Hum Genet. 1995 May;56(5):1238-40
references.pmid: 7726182
references.citation: Arch Neurol. 2012 Mar;69(3):331-8
references.pmid: 22410442
references.citation: Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5592-6
references.pmid: 1648225
references.citation: Brain. 2011 Sep;134(Pt 9):e188
references.pmid: 21810891
references.citation: PLoS One. 2011 Mar 31;6(3):e17963
references.pmid: 21483849
references.citation: Invest Ophthalmol Vis Sci. 2009 Sep;50(9):4205-14
references.pmid: 19387075
references.citation: Hum Gene Ther. 2012 Jun;23(6):647-57
references.pmid: 22390282
references.citation: J Bioenerg Biomembr. 2004 Aug;36(4):387-93
references.pmid: 15377877
references.citation: Nat Rev Genet. 2012 Dec;13(12):878-90
references.pmid: 23154810
references.citation: Mol Cell Biol. 2004 Nov;24(22):9823-34
references.pmid: 15509786
references.citation: J Neuroophthalmol. 2000 Sep;20(3):166-70
references.pmid: 11001192
references.citation: Mitochondrion. 2009 Jun;9(3):196-203
references.pmid: 19460293
references.citation: Brain. 2011 Sep;134(Pt 9):2677-86
references.pmid: 21788663
references.citation: Genetics. 2003 Oct;165(2):707-20
references.pmid: 14573482
references.citation: Biosci Rep. 2007 Jun;27(1-3):125-37
references.pmid: 17486439
references.citation: Biochem J. 2003 Mar 15;370(Pt 3):751-62
references.pmid: 12467494
references.citation: Prog Retin Eye Res. 2011 Mar;30(2):81-114
references.pmid: 21112411
references.citation: Lancet. 1992 Aug 8;340(8815):368-9
references.pmid: 1353825
references.citation: Mol Genet Metab. 2003 Sep-Oct;80(1-2):170-80
references.pmid: 14567966
references.citation: Am J Hum Genet. 2008 Sep;83(3):373-87
references.pmid: 18771762
references.citation: Brain. 2001 Jan;124(Pt 1):209-18
references.pmid: 11133798
references.citation: Curr Treat Options Neurol. 2009 Nov;11(6):414-30
references.pmid: 19891905
references.citation: Hum Mutat. 1995;6(4):311-25
references.pmid: 8680405
references.citation: Eur J Pharm Sci. 2006 Mar;27(4):311-9
references.pmid: 16376528
references.citation: Ophthalmic Genet. 2010 Dec;31(4):196-9
references.pmid: 20809775
references.citation: Hum Reprod Update. 2010 Sep-Oct;16(5):488-509
references.pmid: 20231166
references.citation: Curr Opin Neurol. 2013 Feb;26(1):52-8
references.pmid: 23302804
references.citation: PLoS One. 2012;7(8):e42242
references.pmid: 22879922
references.citation: J Control Release. 2004 Oct 19;99(3):435-44
references.pmid: 15451601
references.citation: J Neurol Sci. 1997 May 1;148(1):25-31
references.pmid: 9125387
references.citation: Eur J Biochem. 1999 Apr;261(2):444-51
references.pmid: 10215855
references.citation: Gene Ther. 1999 Dec;6(12):1919-28
references.pmid: 10637443
references.citation: Arch Ophthalmol. 2007 Feb;125(2):268-72
references.pmid: 17296905
references.citation: J Biol Chem. 2000 Dec 22;275(51):39831-6
references.pmid: 10976107
references.citation: Ann Neurol. 2002 May;51(5):630-4
references.pmid: 12112111
references.citation: Science. 1989 Oct 27;246(4929):500-3
references.pmid: 2814477
references.citation: Am J Med Genet A. 2004 Feb 1;124A(4):377-82
references.pmid: 14735585
references.citation: Am J Hum Genet. 1991 Nov;49(5):939-50
references.pmid: 1928099
references.citation: J Ophthalmol. 2011;2011:179412
references.pmid: 21253496
references.citation: Ann Neurol. 2002 Nov;52(5):534-42
references.pmid: 12402249
references.citation: J Biol Chem. 2004 Apr 9;279(15):14473-6
references.pmid: 14973134
references.citation: Br J Cancer. 2004 Mar 22;90(6):1252-8
references.pmid: 15026809
references.citation: Ophthalmic Genet. 2002 Sep;23(3):191-7
references.pmid: 12324878
references.citation: Am J Hum Genet. 1998 Jan;62(1):196-202
references.pmid: 9443868
references.citation: Nature. 2013 Jan 31;493(7434):627-31
references.pmid: 23103867
references.citation: Mol Pharmacol. 1997 Aug;52(2):300-5
references.pmid: 9271353
references.citation: Crit Rev Biomed Eng. 2009;37(4-5):321-53
references.pmid: 20528730
references.citation: Science. 1988 Dec 9;242(4884):1427-30
references.pmid: 3201231
references.citation: J Control Release. 2003 Sep 19;92(1-2):189-97
references.pmid: 14499196
references.citation: Gene Ther. 2012 May;19(5):469-75
references.pmid: 21918550
references.citation: Invest Ophthalmol Vis Sci. 2007 Feb;48(2):681-91
references.pmid: 17251466
references.citation: Rejuvenation Res. 2005 Spring;8(1):18-28
references.pmid: 15798371
references.citation: J Med Genet. 2002 Mar;39(3):162-9
references.pmid: 11897814